IRIS Accounts Production v26.3.0.614 09807440 Board of Directors 1.8.24 31.1.26 31.1.26 Medium entities true true false true true false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh098074402024-07-31098074402026-01-31098074402024-08-012026-01-31098074402023-07-31098074402023-08-012024-07-31098074402024-07-3109807440ns15:EnglandWales2024-08-012026-01-3109807440ns14:PoundSterling2024-08-012026-01-3109807440ns10:Director12024-08-012026-01-3109807440ns10:PrivateLimitedCompanyLtd2024-08-012026-01-3109807440ns10:MediumEntities2024-08-012026-01-3109807440ns10:Audited2024-08-012026-01-3109807440ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-08-012026-01-3109807440ns10:Medium-sizedCompaniesRegimeForAccounts2024-08-012026-01-3109807440ns10:FullAccounts2024-08-012026-01-3109807440ns10:OrdinaryShareClass12024-08-012026-01-3109807440ns10:Director22024-08-012026-01-3109807440ns10:Director32024-08-012026-01-3109807440ns10:RegisteredOffice2024-08-012026-01-3109807440ns5:CurrentFinancialInstruments2026-01-3109807440ns5:CurrentFinancialInstruments2024-07-3109807440ns5:ShareCapital2026-01-3109807440ns5:ShareCapital2024-07-3109807440ns5:RetainedEarningsAccumulatedLosses2026-01-3109807440ns5:RetainedEarningsAccumulatedLosses2024-07-3109807440ns5:ShareCapital2023-07-3109807440ns5:RetainedEarningsAccumulatedLosses2023-07-3109807440ns5:RetainedEarningsAccumulatedLosses2023-08-012024-07-3109807440ns5:RetainedEarningsAccumulatedLosses2024-08-012026-01-310980744012024-08-012026-01-310980744012023-08-012024-07-310980744012024-08-012026-01-3109807440ns5:LeaseholdImprovements2024-08-012026-01-3109807440ns5:PlantMachinery2024-08-012026-01-3109807440ns5:MotorVehicles2024-08-012026-01-3109807440ns10:HighestPaidDirector2024-08-012026-01-3109807440ns5:OwnedAssets2024-08-012026-01-3109807440ns5:OwnedAssets2023-08-012024-07-3109807440ns5:LeaseholdImprovements2024-07-3109807440ns5:PlantMachinery2024-07-3109807440ns5:MotorVehicles2024-07-3109807440ns5:LeaseholdImprovements2026-01-3109807440ns5:PlantMachinery2026-01-3109807440ns5:MotorVehicles2026-01-3109807440ns5:LeaseholdImprovements2024-07-3109807440ns5:PlantMachinery2024-07-3109807440ns5:MotorVehicles2024-07-3109807440ns5:CostValuation2024-07-3109807440ns5:DisposalsRepaymentsInvestments2026-01-3109807440ns5:CostValuation2026-01-3109807440ns5:Subsidiary12024-08-012026-01-31098074401ns5:Subsidiary12024-08-012026-01-3109807440ns5:Subsidiary12026-01-3109807440ns5:Subsidiary12024-07-3109807440ns5:Subsidiary12024-07-3109807440ns5:Subsidiary12023-08-012024-07-3109807440ns5:Subsidiary22024-08-012026-01-3109807440ns5:Subsidiary232024-08-012026-01-3109807440ns5:Subsidiary22026-01-3109807440ns5:Subsidiary22024-07-3109807440ns5:Subsidiary22023-08-012024-07-3109807440ns5:Subsidiary32024-08-012026-01-31098074405ns5:Subsidiary32024-08-012026-01-3109807440ns5:Subsidiary32026-01-3109807440ns5:Subsidiary32024-07-3109807440ns5:Subsidiary32023-08-012024-07-3109807440ns5:Subsidiary42024-08-012026-01-3109807440ns5:Subsidiary472024-08-012026-01-3109807440ns5:Subsidiary42026-01-3109807440ns5:Subsidiary42024-07-3109807440ns5:Subsidiary42023-08-012024-07-3109807440ns5:Subsidiary52024-08-012026-01-31098074409ns5:Subsidiary52024-08-012026-01-3109807440ns5:Subsidiary52026-01-3109807440ns5:Subsidiary52024-07-3109807440ns5:Subsidiary52023-08-012024-07-3109807440ns5:Subsidiary62024-08-012026-01-3109807440ns5:Subsidiary6112024-08-012026-01-3109807440ns5:Subsidiary62026-01-3109807440ns5:Subsidiary62024-07-3109807440ns5:Subsidiary62023-08-012024-07-3109807440ns5:Subsidiary72024-08-012026-01-310980744013ns5:Subsidiary72024-08-012026-01-3109807440ns5:Subsidiary72026-01-3109807440ns5:Subsidiary72024-07-3109807440ns5:Subsidiary72023-08-012024-07-3109807440ns5:Subsidiary82024-08-012026-01-3109807440ns5:Subsidiary8152024-08-012026-01-3109807440ns5:Subsidiary82026-01-3109807440ns5:Subsidiary82024-07-3109807440ns5:Subsidiary82023-08-012024-07-3109807440ns5:Subsidiary92024-08-012026-01-310980744017ns5:Subsidiary92024-08-012026-01-3109807440ns5:Subsidiary92026-01-3109807440ns5:Subsidiary92024-07-3109807440ns5:Subsidiary92023-08-012024-07-3109807440ns5:Subsidiary102024-08-012026-01-310980744019ns5:Subsidiary102024-08-012026-01-3109807440ns5:Subsidiary102026-01-3109807440ns5:Subsidiary102024-07-3109807440ns5:Subsidiary102023-08-012024-07-3109807440ns5:Subsidiary112024-08-012026-01-310980744021ns5:Subsidiary112024-08-012026-01-3109807440ns5:Subsidiary112026-01-3109807440ns5:Subsidiary112024-07-3109807440ns5:Subsidiary112023-08-012024-07-3109807440ns5:Subsidiary122024-08-012026-01-310980744023ns5:Subsidiary122024-08-012026-01-3109807440ns5:Subsidiary122026-01-3109807440ns5:Subsidiary122024-07-3109807440ns5:Subsidiary122023-08-012024-07-3109807440ns5:WithinOneYearns5:CurrentFinancialInstruments2026-01-3109807440ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3109807440ns5:AcceleratedTaxDepreciationDeferredTax2026-01-3109807440ns5:AcceleratedTaxDepreciationDeferredTax2024-07-3109807440ns5:DeferredTaxation2024-07-3109807440ns5:DeferredTaxation2026-01-3109807440ns10:OrdinaryShareClass12026-01-3109807440ns5:RetainedEarningsAccumulatedLosses2024-07-3109807440ns10:Director332024-07-3109807440ns10:Director332023-07-3109807440ns10:Director332024-08-012026-01-3109807440ns10:Director332023-08-012024-07-3109807440ns10:Director332026-01-3109807440ns10:Director332024-07-310980744012024-08-012026-01-31
REGISTERED NUMBER: 09807440 (England and Wales)















Strategic Report, Report of the Directors and

Financial Statements for the Period 1 August 2024 to 31 January 2026

for

Evolve Care Group (A) Ltd

Evolve Care Group (A) Ltd (Registered number: 09807440)






Contents of the Financial Statements
for the Period 1 August 2024 to 31 January 2026




Page

Company Information 1

Strategic Report 2

Report of the Directors 6

Report of the Independent Auditors 8

Income Statement 12

Other Comprehensive Income 13

Balance Sheet 14

Statement of Changes in Equity 15

Cash Flow Statement 16

Notes to the Cash Flow Statement 17

Notes to the Financial Statements 18


Evolve Care Group (A) Ltd

Company Information
for the Period 1 August 2024 to 31 January 2026







DIRECTORS: R D Burton
Mrs E Carder
SPD001 Limited



REGISTERED OFFICE: Beech House
Brotherswood Court
Almondsbury
Bristol
BS32 4QW



REGISTERED NUMBER: 09807440 (England and Wales)



SENIOR STATUTORY AUDITOR: Matthew Dobbins FCA



AUDITORS: Dunkley's Chartered Certified Accountants
Woodlands Grange
Woodlands Lane
Bradley Stoke
BS32 4JY

Evolve Care Group (A) Ltd (Registered number: 09807440)

Strategic Report
for the Period 1 August 2024 to 31 January 2026

The directors present their strategic report for the period 1 August 2024 to 31 January 2026.

PRINCIPLE ACTIVITY
The group operates leasehold interest in residential and nursing care homes for the elderly. The group aims to focus on providing care for individuals who present with high and complex care needs.

REVIEW OF BUSINESS
The group has developed operational expertise in dedicated facilities that support higher levels of acuity. The group has undertaken a global (Australia, USA, Middle-East, Europe) research initiative in order to identify pioneering and best practice. It has developed a specialist training programme that is delivered in person to all team members. The group aims to hold true to its core values and remains committed to all individuals who work with the group and those people being supported with care.

With the most recent additions to the group being under-performing and non-compliant care businesses, the Group remains focused on implementing its 5-year strategy aimed at realising value through quality improvement, stabilisation, consolidation, and refinement of existing trade. The introduction of high acuity care beds has resulted in an ability to iterate and improve existing models of training and operation to better meet the needs of this demographic.

The group seeks to ensure it operates as part of the sector and not as an isolated provider; it remains a core tenet of the organisation to service the needs of the larger social care community through a philosophy of transparent, pragmatic, and reflective joint working.

The group seeks to utilise expertise within its whole team to grow and develop as an organisation. Specific activities have been undertaken to ensure that not only traditional management roles but any role in which leadership qualities and decisions impact the outcome of the organisation are given a voice that can input into the overall group direction. Additional training and coaching has been deployed to those who fill these positions to ensure they are supported in this endeavour. It is the intent of the group to promote this larger leadership team approach to ensure end-to-end fulfilment of the groups objectives.

The group regularly monitors KPIs in alignment with the industry in which it operates, directors have monitored the group's progress in the year by use of financial and non-financial KPIs such as turnover of £31.8m (£40.4m 2023), EBITDA, staff costs, non-staff costs, and occupancy - these are considered standard KPIs across the industry. All banking covenants continued to be met. Exceptional items have been disclosed in the notes separately.


Evolve Care Group (A) Ltd (Registered number: 09807440)

Strategic Report
for the Period 1 August 2024 to 31 January 2026

PRINCIPAL RISKS AND UNCERTAINTIES
The Group focuses on consolidation of existing trade practices with a view to grow through improvements in quality, specialisation, and by positioning as a provider of higher acuity care. The group continually evaluates a range of quantitative and qualitative risks facing the business and classifies them according to the priority in which they should be dealt with (given the Group's available resources). It should be noted that some of the risks are rated as significant or high.

The group recognises its key risks and seeks to address them through targeted adjustments to operations, group positioning within the market, and in how it pursues its strategic objectives.


Environment
The group's leasehold sites consist of primarily converted properties with only three purpose built nursing homes. The most recently acquired properties experienced a significant lack of capital investment, it is understood that the previous owners were unable to obtain finance for a capital investment programme. As such most of the properties entered the groups portfolio outdated, poorly maintained, and most importantly still require significant expenditure to ensure the ongoing regulatory compliance and operation of fire prevention systems, electrical installations, nurse call systems, lifts and boilers. With the addition of sites already in a poor state of repair to the existing portfolio, requirements have meant the group commenced and remains committed to an on-going and significant schedule of works to bring the estates to the appropriate level of required compliance, to improve care outcomes through renewed environmental design, and to improve the aesthetics to be in line with competitors.

Regulatory Environment
The group's activities are subject to inspection by Care Inspectorate Wales (CIW) and Care Quality Commissions (CQC). Risk from the negative effects of non-compliance or reduced inspection ratings may impact the groups reputation and profits. Risks are mitigated through maintaining relationships and closely working with regulators and external professionals to ensure that clear and effective channels of communication remain open to address issues. The group focuses on ensuring that training, policies, and daily operations work towards a position that mitigates the risk of non-compliance or reduced inspection ratings. Where adverse regulatory events occur; robust and collaborative systems trigger re-direction of operations back to a position of safety.

People Living at the homes with a higher level of dementia, autism, learning disabilities, other mental health needs
A group decision was made to specialise delivery of care and focus on people living with a higher acuity of dementia. The Directors have globally (Australia, USA, Middle-East, Europe) researched a number of models of care and believe that the one they have implemented provides the best possible outcomes for people living at the homes. The model specialises in supporting extremely dependent people. This results in a requirement for high numbers of specialist staff. This is a significant cost and challenge to meet operationally. The intensity of the care required also means that there is a high turnover of staff leading to surges of unplanned agency use and the requirement for extra quality assurance personnel, a need which is fulfilled by consultants. The majority of those living at the groups sites are financially supported by the local authority or NHS. The Directors have looked beyond short term profit to favour long term sustainability and the quality of experience that people living at each site receive on a daily basis. The directors believe that delivering an excellent experience with premium levels of care is not only consistent with their duty of care to people living in the homes but also consistent with their fiduciary duty to build long term, sustainable stakeholder value.

Locations
The Groups' homes are disparate and principally in rural locations. This poses a number of challenges to attracting new people to live and work at each site. The risks posed by operating remote locations with respect to staffing are mitigated by working closing with local landlords and housing to facilitate an offering of properties that enable re-location both domestically and internationally. The Directors are aware that the Landlords are in dispute regarding legal boundaries and sewerage at two of the sites. If not resolved this may impact continued operations.

Office
The Directors relocated their central support team to a new office building in 2022, which continues to be occupied. Terms for the use of the office space have been agreed under license from related parties. Whilst this presents a risk to continued operations it also provides maximum flexibility in the short term.

Operating Model
The Group has continued its focus on the delivery of care and has taken licences to use an operating model including all handbooks, systems and processes for the operation of the business from related parties. Whilst renewal terms for the licence presents a risk to continued operations it enables the Group to focus on the core delivery of care.

Technology
The Group has identified comprehensive new technological platforms and has commenced implementation to achieve an expanded technological infrastructure to enable operational goals and meet developing market requirements. The Directors are currently reviewing the best options to prioritise works and in the interim have arrangements covering email, accounting and other critical operational functions such that the need is fulfilled with short term licences from related parties until all upgrades are completed. Whilst renewal terms for the licence presents a risk to continued operations it enables the Group to focus on the core delivery of care and to remain flexibility in its on-going development of appropriate technology.

Evolve Care Group (A) Ltd (Registered number: 09807440)

Strategic Report
for the Period 1 August 2024 to 31 January 2026


Consultants
The Group is actively recruiting for Senior roles. In the interim it has engaged a number of Consultants, many of whom are able to work remotely, to undertake critical roles. The ongoing engagement of these Consultants is considered to be important for the maintenance of continuity and as such terms have been agreed to incentivise their retention.

Financial
The Group has an on-going relationship with a long term funder for the business, who support the long term development and growth of the group.

Training
The Group has invested in a specialist bespoke training programme delivered by related parties and external consultants. This includes leadership training provided to both senior central teams, as well as individuals working within each care setting. A significant number of employees have a contractual entitlement to this training with a payment in lieu if it is not delivered. There is therefore a risk of staff leaving or claiming compensation of the training from related parties is not maintained.

Staffing
Recruitment and retention are key areas of focus of the group, with initiatives undertaken to support this position. Maintaining a strong and consistent operating team has been fundamental in ensuring the goals of the organisation are realised. A similar level of consistency of on-the-ground staffing is critical to continued success of each site through the provision of the highest quality care and to mitigate the attrition of skill inherent to high turnover. The organisation structures its management of revenue to ensure levels of staffing that facilitate successful care delivery are affordable. Significant consideration and resource is allocated to ensuring that projected National Living Wage changes can be navigated without detrimental impact to staffing or financial viability. The group places specific emphasis on ensuring the revenue generated from care activities is commensurate to the care being provided and works closely with funders to maintain this position.

FINANCIAL INSTRUMENTS
The group's principal financial instruments comprise bank balances, bank overdrafts, trade creditors, trade debtors, loans to the group and finance lease agreements. The main purpose of these instruments is to raise funds for the group's operations and to finance the group's operations.

The group manages the liquidity risk by ensuring that there are sufficient funds to meet the payments for its financial commitments. The loans are on commercial terms and payable on certain criteria being met.

Trade debtors are managed in respect of credit and cash flow risk by policies concerning the credit offered to customers and the regular monitoring of amounts outstanding for both time and credit limits.

STRATEGY
The group's success is dependent on pricing and ongoing management of the care that is provided. The Care Quality Commission (CQC) and the Care Inspectorate Wales (CIW) are the two organisations that monitor and inspect the nursing homes to ensure that the minimum standards required in legislation are being met. The focus at the sites on creating a community that offers activity, independence, and choice - giving the people living in them the choice to live their lives the way they really want. The group will continue to consolidate its position and concentrate its effort on achieving profitable growth in turnover. The group aims to improve efficiency in all areas of our operations through cost reduction; more disciplined budgeting and more effective management. Customer service and the residents' welfare remain the top priority. The group places significant importance on staff training. The group proactively encourages all staff members to complete training courses to ensure that each member of staff is equipped to provide the best possible care. Substantial resources have been dedicated to a training system to achieve this.


Evolve Care Group (A) Ltd (Registered number: 09807440)

Strategic Report
for the Period 1 August 2024 to 31 January 2026

EMPLOYEE INVOLVEMENT, EMPLOYMENT OF DISABLED PERSONS AND TRAINING
Full and fair consideration is given to applications for employment of disabled persons having regard to their particular aptitude and abilities. Wherever possible, provision is made for training, career development and promotion of disabled employees. Every effort is made to facilitate and support the continued employment of employees who become disabled during their employment. The group has continued its' policy of employee involvement, by making information available to employees and encouraging their participation in schemes which are related to the group's progress and profitability. The group has enlisted the services of various training organisations and local colleges to provide training across all its' homes and head office in professional qualifications, NVQs, COSHH, Manual Handling and a structured internal training programme for all staff.

ON BEHALF OF THE BOARD:



R D Burton - Director


30 October 2026

Evolve Care Group (A) Ltd (Registered number: 09807440)

Report of the Directors
for the Period 1 August 2024 to 31 January 2026

The directors present their report with the financial statements of the company for the period 1 August 2024 to 31 January 2026.

PRINCIPAL ACTIVITY
The principal activity of the company in the period under review was that of the specialist provision of quality long term care for the elderly through the leasehold management and operation of care homes offering residential and nursing care.

DIVIDENDS
No dividends will be distributed for the period ended 31 January 2026.

EVENTS SINCE THE END OF THE PERIOD
Information relating to events since the end of the period is given in the notes to the financial statements.
The directors have considered events occurring between the balance sheet date and the date on which the financial statements were authorised for issue and have concluded that there are no material adjusting or non-adjusting events requiring disclosure in these financial statements.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 August 2024 to the date of this report.

R D Burton
Mrs E Carder
SPD001 Limited

FINANCIAL INSTRUMENTS
The company has elected to apply the provisions of Sections 11 and 12 of FRS 102 in respect of financial instruments. Basic financial assets, including trade and other debtors, amounts owed by group undertakings and cash at bank and in hand, are recognised initially at transaction price and subsequently measured at amortised cost, less any impairment. Basic financial liabilities, including trade and other creditors, accruals and amounts owed to group undertakings, are recognised initially at transaction price and subsequently measured at amortised cost. Financial assets are reviewed for indicators of impairment at each reporting date.

POLITICAL DONATIONS AND EXPENDITURE
Donations made in the year were to charitable causes. No donations were made to any political party.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

Evolve Care Group (A) Ltd (Registered number: 09807440)

Report of the Directors
for the Period 1 August 2024 to 31 January 2026


AUDITORS
The auditors, Dunkley's Chartered Certified Accountants, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





R D Burton - Director


30 October 2026

Report of the Independent Auditors to the Members of
Evolve Care Group (A) Ltd

Opinion
We have audited the financial statements of Evolve Care Group (A) Ltd (the 'company') for the period ended 31 January 2026 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 January 2026 and of its profit for the period then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

The financial statements have been prepared on a going concern basis. The company is dependent upon the continuing financial support of its parent undertaking and fellow group companies. The directors have received confirmation that such support will continue for the foreseeable future and have reviewed forecasts and cash flow projections covering a period of at least twelve months from the date of approval of the financial statements. On this basis, the directors consider it appropriate to prepare the financial statements on the going concern basis.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Evolve Care Group (A) Ltd


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page six, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Evolve Care Group (A) Ltd


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Extent to which the audit was considered capable of detecting irregularities, including fraud

We identify and assess the risks of material misstatement in the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. We obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion.

Identifying and assessing potential risks related to irregularities

In identifying and assessing the risks of material misstatement arising from irregularities, including fraud and non-compliance with laws and regulations, we considered:
The nature of the industry and sector, the control environment and business performance, including the design of the company's remuneration policies, bonus arrangements and performance targets.
Matters identified through obtaining and reviewing the company's policies and procedures relating to:
- identifying, evaluating and complying with laws and regulations, including whether management was aware of any instances of non-compliance;
- detecting and responding to the risks of fraud and whether management had knowledge of any actual, suspected or alleged fraud; and
- the internal controls established to mitigate the risks of fraud or non-compliance with laws and regulations.
Matters discussed by the audit engagement team regarding how and where fraud might occur in the financial statements, including any potential indicators of fraud.

As a result of these procedures, we considered the opportunities and incentives that may exist within the organisation for fraud and identified the greatest potential for fraud in the areas of management override of controls and revenue recognition.
We also obtained an understanding of the legal and regulatory framework within which the company operates, focusing on those laws and regulations that have a direct effect on the determination of material amounts and disclosures in the financial statements.

Audit response to risks identified
Our procedures to respond to the risks identified included:
Enquiries of management concerning actual and potential litigation and claims.
Performing analytical procedures to identify unusual or unexpected relationships that may indicate risks of material misstatement arising from fraud.
In addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments, assessing whether the judgements made in accounting estimates indicate potential bias, and evaluating the business rationale for significant transactions that are unusual or outside the normal course of business.

We also communicated relevant identified laws and regulations and potential fraud risks to all members of the engagement team and remained alert throughout the audit for indications of fraud or non-compliance with laws and regulations.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of
Evolve Care Group (A) Ltd


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Matthew Dobbins FCA (Senior Statutory Auditor)
for and on behalf of Dunkley's Chartered Certified Accountants
Woodlands Grange
Woodlands Lane
Bradley Stoke
BS32 4JY

30 October 2026

Evolve Care Group (A) Ltd (Registered number: 09807440)

Income Statement
for the Period 1 August 2024 to 31 January 2026

Period
1.8.24
to Year Ended
31.1.26 31.7.24
Notes £    £   

TURNOVER 9,158 1,977

Cost of sales 104,547 90,265
GROSS LOSS (95,389 ) (88,288 )

Administrative expenses 2,440,527 1,133,506
(2,535,916 ) (1,221,794 )

Other operating income 3,694,579 1,158,453
OPERATING PROFIT/(LOSS) 4 1,158,663 (63,341 )

Profit/loss on sale of operatn 5 1,000 -
1,157,663 (63,341 )

Interest receivable and similar income - 64
PROFIT/(LOSS) BEFORE TAXATION 1,157,663 (63,277 )

Tax on profit/(loss) 6 367,540 (17,293 )
PROFIT/(LOSS) FOR THE FINANCIAL PERIOD 790,123 (45,984 )

Evolve Care Group (A) Ltd (Registered number: 09807440)

Other Comprehensive Income
for the Period 1 August 2024 to 31 January 2026

Period
1.8.24
to Year Ended
31.1.26 31.7.24
Notes £    £   

PROFIT/(LOSS) FOR THE PERIOD 790,123 (45,984 )


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR THE
PERIOD

790,123

(45,984

)

Evolve Care Group (A) Ltd (Registered number: 09807440)

Balance Sheet
31 January 2026

31.1.26 31.7.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 7 213,605 267,671
Investments 8 5,800 6,800
219,405 274,471

CURRENT ASSETS
Debtors 9 14,847,097 15,304,021
Cash at bank and in hand 6,332,449 3,536,597
21,179,546 18,840,618
CREDITORS
Amounts falling due within one year 10 14,197,551 12,702,240
NET CURRENT ASSETS 6,981,995 6,138,378
TOTAL ASSETS LESS CURRENT LIABILITIES 7,201,400 6,412,849

PROVISIONS FOR LIABILITIES 13 31,151 32,723
NET ASSETS 7,170,249 6,380,126

CAPITAL AND RESERVES
Called up share capital 14 1,000 1,000
Retained earnings 15 7,169,249 6,379,126
SHAREHOLDERS' FUNDS 7,170,249 6,380,126

The financial statements were approved by the Board of Directors and authorised for issue on 30 October 2026 and were signed on its behalf by:





R D Burton - Director


Evolve Care Group (A) Ltd (Registered number: 09807440)

Statement of Changes in Equity
for the Period 1 August 2024 to 31 January 2026

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 August 2023 1,000 6,425,110 6,426,110

Changes in equity
Total comprehensive income - (45,984 ) (45,984 )
Balance at 31 July 2024 1,000 6,379,126 6,380,126

Changes in equity
Total comprehensive income - 790,123 790,123
Balance at 31 January 2026 1,000 7,169,249 7,170,249

Evolve Care Group (A) Ltd (Registered number: 09807440)

Cash Flow Statement
for the Period 1 August 2024 to 31 January 2026

Period
1.8.24
to Year Ended
31.1.26 31.7.24
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 8,097,582 4,718,634
Tax paid (7,756 ) -
Net cash from operating activities 8,089,826 4,718,634

Cash flows from investing activities
Purchase of tangible fixed assets (98,811 ) (41,815 )
Purchase of fixed asset investments - (200 )
Sale of tangible fixed assets - (139 )
Sale of fixed asset investments 1,000 -
Interest received - 64
Net cash from investing activities (97,811 ) (42,090 )

Cash flows from financing activities
Loan movements with connected parties (5,184,739 ) (4,364,944 )
Amount withdrawn by directors (11,424 ) (208,176 )
Net cash from financing activities (5,196,163 ) (4,573,120 )

Increase in cash and cash equivalents 2,795,852 103,424
Cash and cash equivalents at beginning of
period

2

3,536,597

3,433,173

Cash and cash equivalents at end of period 2 6,332,449 3,536,597

Evolve Care Group (A) Ltd (Registered number: 09807440)

Notes to the Cash Flow Statement
for the Period 1 August 2024 to 31 January 2026

1. RECONCILIATION OF PROFIT/(LOSS) BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

Period
1.8.24
to Year Ended
31.1.26 31.7.24
£    £   
Profit/(loss) before taxation 1,157,663 (63,277 )
Depreciation charges 152,877 103,003
Loss on disposal of fixed assets - 139
Finance income - (64 )
1,310,540 39,801
Decrease in trade and other debtors 8,007,279 5,041,509
Decrease in trade and other creditors (1,220,237 ) (362,676 )
Cash generated from operations 8,097,582 4,718,634

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Period ended 31 January 2026
31.1.26 1.8.24
£    £   
Cash and cash equivalents 6,332,449 3,536,597
Year ended 31 July 2024
31.7.24 1.8.23
£    £   
Cash and cash equivalents 3,536,597 3,433,173

Cash and cash equivalents comprise cash at bank and in hand and short-term deposits with an original maturity of three months or less.


3. ANALYSIS OF CHANGES IN NET FUNDS

At 1.8.24 Cash flow At 31.1.26
£    £    £   
Net cash
Cash at bank and in hand 3,536,597 2,795,852 6,332,449
3,536,597 2,795,852 6,332,449
Total 3,536,597 2,795,852 6,332,449

4. DISPOSAL OF BUSINESS

On 8 April 2025, the company disposed of its interest in Ramram Care Services 2 Limited for nil consideration. The investment has been derecognised and the resulting loss on disposal has been recognised in the profit and loss account.

Evolve Care Group (A) Ltd (Registered number: 09807440)

Notes to the Financial Statements
for the Period 1 August 2024 to 31 January 2026

1. STATUTORY INFORMATION

Evolve Care Group (A) Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in Pound Sterling (£), which is also the company's functional currency. Monetary amounts in these financial statements are rounded to the nearest pound.

Preparation of consolidated financial statements
The financial statements contain information about Evolve Care Group (A) Ltd as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 400 of the Companies Act 2006 from the requirements to prepare consolidated financial statements as it and its subsidiary undertaking are included by full consolidation in the consolidated financial statements of its parent, SPD001 Limited, Beech House, Brotherswood Court, Almondsbury, Bristol, England, BS32 4QW.

The Company’s immediate and ultimate parent undertaking is SPD001 Limited, a company incorporated and registered in England and Wales (company number 12133415), with its registered office at Beech House, Brotherswood Court, Almondsbury, Bristol, BS32 4QW.

SPD001 Limited is the parent undertaking of both the smallest and the largest group of undertakings for which consolidated financial statements are prepared that include the Company. Copies of the consolidated financial statements of SPD001 Limited can be obtained from the Registrar of Companies, Companies House, Crown Way, Cardiff, CF14 3UZ.

There is no single ultimate controlling party.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying value of assets and liabilities that are not readily apparent from other sources. The estimates and underlying assumptions are based on historical experience and other factors considered to be relevant. Actual results may differ from these estimates.

The principal areas of estimation uncertainty include the useful economic lives of tangible fixed assets, the recoverability of trade debtors and intercompany balances, and the assessment of any impairment indicators in respect of assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes, in relation to the provision of care services, agency fees and ad-hoc commissions.

All of the company's revenue was generated within the United Kingdom.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 20% on cost
Plant and machinery - 20% on cost
Motor vehicles - 20% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost less impairment.

Evolve Care Group (A) Ltd (Registered number: 09807440)

Notes to the Financial Statements - continued
for the Period 1 August 2024 to 31 January 2026

2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Sections 11 and 12 of FRS 102 in respect of financial instruments. Basic financial assets, including trade and other debtors, amounts owed by group undertakings and cash at bank and in hand, are recognised initially at transaction price and subsequently measured at amortised cost, less any impairment. Basic financial liabilities, including trade and other creditors, accruals and amounts owed to group undertakings, are recognised initially at transaction price and subsequently measured at amortised cost. Financial assets are reviewed for indicators of impairment at each reporting date.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Nature of support from group companies
The financial statements have been prepared on a going concern basis. The company is dependent upon the continuing financial support of its parent undertaking and fellow group companies. The directors have received confirmation that such support will continue for the foreseeable future and have reviewed forecasts and cash flow projections covering a period of at least twelve months from the date of approval of the financial statements. On this basis, the directors consider it appropriate to prepare the financial statements on the going concern basis.

3. EMPLOYEES AND DIRECTORS
Period
1.8.24
to Year Ended
31.1.26 31.7.24
£    £   
Wages and salaries 355,181 166,366
Social security costs 29,980 20,802
Other pension costs 6,260 4,063
391,421 191,231

Evolve Care Group (A) Ltd (Registered number: 09807440)

Notes to the Financial Statements - continued
for the Period 1 August 2024 to 31 January 2026

3. EMPLOYEES AND DIRECTORS - continued

The average number of employees during the period was as follows:
Period
1.8.24
to Year Ended
31.1.26 31.7.24

Directors 3 3
Management & Administration Staff 62 46
65 49

Period
1.8.24
to Year Ended
31.1.26 31.7.24
£    £   
Directors' remuneration 212,457 135,586
Directors' pension contributions to money purchase schemes 19,481 2,649

Information regarding the highest paid director for the period ended 31 January 2026 is as follows:
Period
1.8.24
to
31.1.26
£   
Emoluments etc 129,983
Pension contributions to money purchase schemes 11,636

4. OPERATING PROFIT/(LOSS)

The operating profit (2024 - operating loss) is stated after charging:

Period
1.8.24
to Year Ended
31.1.26 31.7.24
£    £   
Depreciation - owned assets 152,877 103,002
Loss on disposal of fixed assets - 139
Auditors' remuneration 65,610 -
Auditors' remuneration for non audit work - (9,000 )

5. EXCEPTIONAL ITEMS
Period
1.8.24
to Year Ended
31.1.26 31.7.24
£    £   
Profit/loss on sale of operatn (1,000 ) -

Evolve Care Group (A) Ltd (Registered number: 09807440)

Notes to the Financial Statements - continued
for the Period 1 August 2024 to 31 January 2026

6. TAXATION

Analysis of the tax charge/(credit)
The tax charge/(credit) on the profit for the period was as follows:
Period
1.8.24
to Year Ended
31.1.26 31.7.24
£    £   
Current tax:
UK corporation tax 369,112 -

Deferred tax (1,572 ) (17,293 )
Tax on profit/(loss) 367,540 (17,293 )

Reconciliation of total tax charge/(credit) included in profit and loss
The tax assessed for the period is higher than the standard rate of corporation tax in the UK. The difference is explained below:

Period
1.8.24
to Year Ended
31.1.26 31.7.24
£    £   
Profit/(loss) before tax 1,157,663 (63,277 )
Profit/(loss) multiplied by the standard rate of corporation tax in the UK of 25%
(2024 - 25%)

289,416

(15,819

)

Effects of:
Expenses not deductible for tax purposes 4,009 1,391
Depreciation in excess of capital allowances 3,054 10,534
Utilisation of tax losses - 3,894
Correction to deferred tax (1,572 ) (17,293 )


Tax on loans to participators (s455) 74,115 -
Other timing differences (1,482 ) -
Total tax charge/(credit) 367,540 (17,293 )

Evolve Care Group (A) Ltd (Registered number: 09807440)

Notes to the Financial Statements - continued
for the Period 1 August 2024 to 31 January 2026

7. TANGIBLE FIXED ASSETS
Improvements
to Plant and Motor
property machinery vehicles Totals
£    £    £    £   
COST
At 1 August 2024 - 585,916 85,000 670,916
Additions 7,589 91,222 - 98,811
At 31 January 2026 7,589 677,138 85,000 769,727
DEPRECIATION
At 1 August 2024 - 373,856 29,389 403,245
Charge for period 1,966 125,411 25,500 152,877
At 31 January 2026 1,966 499,267 54,889 556,122
NET BOOK VALUE
At 31 January 2026 5,623 177,871 30,111 213,605
At 31 July 2024 - 212,060 55,611 267,671

8. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 August 2024 6,800
Disposals (1,000 )
At 31 January 2026 5,800
NET BOOK VALUE
At 31 January 2026 5,800
At 31 July 2024 6,800

The company's investments at the Balance Sheet date in the share capital of companies include the following:

Angela Court Limited
Registered office: Beech House, Brotherswood Court, Almondsbury, Bristol, England, BS32 4QW
Nature of business: No longer trading
%
Class of shares: holding
Ordinary A 100.00
31.1.26 31.7.24
£    £   
Aggregate capital and reserves (49,379 ) (39,492 )
Loss for the period/year (9,887 ) (36,218 )

Evolve Care Group (A) Ltd (Registered number: 09807440)

Notes to the Financial Statements - continued
for the Period 1 August 2024 to 31 January 2026

8. FIXED ASSET INVESTMENTS - continued

Gibraltar Care Village Ltd
Registered office: Beech House, Brotherswood Court, Almondsbury, Bristol, England, BS32 4QW
Nature of business: Operation of care homes.
%
Class of shares: holding
Ordinary 100.00
31.1.26 31.7.24
£    £   
Aggregate capital and reserves (1,286,780 ) (1,662,868 )
Profit for the period/year 376,088 39,477

Frome Care Village Ltd
Registered office: Beech House, Brotherswood Court, Almondsbury, Bristol, England, BS32 4QW
Nature of business: Operation of care homes.
%
Class of shares: holding
Ordinary A 100.00
31.1.26 31.7.24
£    £   
Aggregate capital and reserves 1,426 (305,305 )
Profit for the period/year 306,731 297,980

Heanton Ltd
Registered office: Beech House, Brotherswood Court, Almondsbury, Bristol, England, BS32 4QW
Nature of business: Operation of care homes
%
Class of shares: holding
Ordinary A 100.00
31.1.26 31.7.24
£    £   
Aggregate capital and reserves 894,247 570,236
Profit/(loss) for the period/year 324,011 (27,467 )

Hatherleigh Care Village Ltd
Registered office: Beech House, Brotherswood Court, Almondsbury, Bristol, England, BS32 4QW
Nature of business: Operation of care homes.
%
Class of shares: holding
Ordinary A 100.00
31.1.26 31.7.24
£    £   
Aggregate capital and reserves 1,381,463 1,088,640
Profit for the period/year 292,823 341,283

Sundial View Ltd
Registered office: Beech House, Brotherswood Court, Almondsbury, Bristol, England, BS32 4QW
Nature of business: Operation of care homes.
%
Class of shares: holding
Ordinary 100.00
31.1.26 31.7.24
£    £   
Aggregate capital and reserves 1,294,949 1,021,998
Profit for the period/year 272,951 215,539

Evolve Care Group (A) Ltd (Registered number: 09807440)

Notes to the Financial Statements - continued
for the Period 1 August 2024 to 31 January 2026

8. FIXED ASSET INVESTMENTS - continued

Edenmore Care Limited
Registered office: Beech House, Brotherswood Court, Almondsbury, Bristol, England, BS32 4QW
Nature of business: Operation of care homes.
%
Class of shares: holding
Ordinary A 100.00
31.1.26 31.7.24
£    £   
Aggregate capital and reserves 1,260,851 956,752
Profit for the period/year 304,099 200,089

TC Operation Ltd
Registered office: Beech House, Brotherswood Court, Almondsbury, Bristol, England, BS32 4QW
Nature of business: Operation of care homes.
%
Class of shares: holding
Ordinary 100.00
31.1.26 31.7.24
£    £   
Aggregate capital and reserves 426,685 173,866
Profit for the period/year 252,819 110,193

RAMRAM CARE SERVICES 2 LIMITED
Registered office: Beech House, Brotherswood Court, Almondsbury, Bristol, England, BS32 4QW
Nature of business: Dormant
%
Class of shares: holding
Ordinary 100.00
31.1.26 31.7.24
£    £   
Aggregate capital and reserves 380 5,522
Profit/(loss) for the period/year 5,902 (1,734 )

On 8 April 2025 TCOPC1 Limited was renamed to Ramram Care Services 2 Limited.

TCOPC Limited
Registered office: Beech House, Brotherswood Court, Almondsbury, Bristol, England, BS32 4QW
Nature of business: Dormant
%
Class of shares: holding
Ordinary 100.00
31.1.26 31.7.24
£    £   
Aggregate capital and reserves (40,426 ) (10,912 )
Loss for the period/year (29,514 ) (7,164 )

Evolve Care Group (A) Ltd (Registered number: 09807440)

Notes to the Financial Statements - continued
for the Period 1 August 2024 to 31 January 2026

8. FIXED ASSET INVESTMENTS - continued

RAMRAM CARE SERVICES 1 LIMITED
Registered office: Beech House, Brotherswood Court, Almondsbury, Bristol, England, BS32 4QW
Nature of business: Dormant
%
Class of shares: holding
Ordinary 100.00
31.1.26 31.7.24
£    £   
Aggregate capital and reserves (9,577 ) (9,483 )
Loss for the period/year (3,094 ) (1,614 )

On 8 April 2025 Thistle Court Operation 1 Limited was renamed to Ramram Care Services 1 Limited.

Thistle Court Ops Ltd
Registered office: Beech House, Brotherswood Court, Almondsbury, Bristol, England, BS32 4QW
Nature of business: Non-trading
%
Class of shares: holding
Ordinary 100.00
31.1.26 31.7.24
£    £   
Aggregate capital and reserves (95,544 ) (95,510 )
Loss for the period/year (34 ) (794 )

9. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.26 31.7.24
£    £   
Amounts owed by group undertakings 14,599,107 7,060,176
Other debtors 2,541 8,024,789
Directors' loan accounts 219,600 208,176
Called up share capital not paid 1,000 1,000
Prepayments and accrued income 24,849 9,880
14,847,097 15,304,021

10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.26 31.7.24
£    £   
Trade creditors 2,796,791 2,810,208
Amounts owed to group undertakings 10,812,958 8,458,766
Tax 166,299 (195,057 )
Social security and other taxes 83,902 86,483
Other creditors 128,327 1,415,804
Accrued expenses 209,274 126,036
14,197,551 12,702,240

11. SECURED DEBTS

Coutts & Company holds a debenture dated 3 July 2020, containing fixed and floating charges over all the property and undertaking of the company. The debenture secures the company’s obligations under a cross-guarantee in respect of the bank borrowings of KKP Borrower Limited, a company under common control.

The company had no bank borrowings of its own at 31 January 2026 (31 July 2024: £nil). At 31 January 2026 the bank borrowings of KKP Borrower Limited secured by this debenture were £21,462,500 (31 July 2024: £23,175,000).

Evolve Care Group (A) Ltd (Registered number: 09807440)

Notes to the Financial Statements - continued
for the Period 1 August 2024 to 31 January 2026

12. FINANCIAL INSTRUMENTS

The company has elected to apply the provisions of Sections 11 and 12 of FRS 102 in respect of financial instruments. Basic financial assets, including trade and other debtors, amounts owed by group undertakings and cash at bank and in hand, are recognised initially at transaction price and subsequently measured at amortised cost, less any impairment. Basic financial liabilities, including trade and other creditors, accruals and amounts owed to group undertakings, are recognised initially at transaction price and subsequently measured at amortised cost. Financial assets are reviewed for indicators of impairment at each reporting date.

13. PROVISIONS FOR LIABILITIES
31.1.26 31.7.24
£    £   
Deferred tax
Accelerated capital allowances 35,065 (11,897 )
Other timing differences (3,914 ) (5,396 )
Deferred tax - 50,016
31,151 32,723

Deferred
tax
£   
Balance at 1 August 2024 32,723
Accelerated Capital Allowances (3,054 )
Losses
Other timing differences 1,482
Balance at 31 January 2026 31,151

14. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.26 31.7.24
value: £    £   
1,000 Ordinary £1 1,000 1,000

15. RESERVES
Retained
earnings
£   

At 1 August 2024 6,379,126
Profit for the period 790,123
At 31 January 2026 7,169,249

16. PENSION COMMITMENTS

During the year, the company operated a defined contribution pension scheme through an external provider.

Employer contributions to the scheme for the year totalled £60,527 (2024 - £52,686).

Accrued pension contributions outstanding at the balance sheet date totalled £15,655 (2024 - £21,582).

17. ULTIMATE PARENT COMPANY

SPD001 Limited is regarded by the directors as being the company's ultimate parent company.

Evolve Care Group (A) Ltd (Registered number: 09807440)

Notes to the Financial Statements - continued
for the Period 1 August 2024 to 31 January 2026

18. CONTINGENT LIABILITIES

In addition the directors acknowledge a contingent liability to shareholders and management in relation to an incentive plan based on the future performance of the group.
The Group operates an incentive plan for certain shareholders and members of senior management. Under the plan, payments may become due based on the Groups EBITDA over a 3 year period ending 31/01/2028.
At the balance sheet date, the directors do not consider it probable that the conditions for payment will be met, so no provision has been recognised.
The directors consider that it is not practicable to estimate the financial effect of the plan. Any amount payable depends on the Group's performance over a period extending to 31/01/2028 which is subject to signifcant uncertainty.The directors will reassess this at each reporting date. No reimbursement is expected in respect of any amount payable.

19. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the period ended 31 January 2026 and the year ended 31 July 2024:

31.1.26 31.7.24
£    £   
SPD001 Limited
Balance outstanding at start of period 208,176 -
Amounts advanced 11,424 208,176
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of period 219,600 208,176

The loan outstanding at year end for SPD001 Ltd is in relation to this company's directors. The loan outstanding of £219,600 was resolved within 9 months of the year end

20. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

During the period the company wrote off loans of 2026 £nil (2024 - £nil) with other related parties. The other parties involved were in agreement of this treatment.

During the period the company received rents of £0 (2024 - £0) from a company under common control.

During the period the company received management charges of £3,446,675 (2024 - £1,155,227) from a company under common control.

As at the 31st January 2026, amounts owed from connected parties outside the group were £4,270,777 (2024, £4,730,749)

21. POST BALANCE SHEET EVENTS

Information relating to events since the end of the period is given in the notes to the financial statements.
The directors have considered events occurring between the balance sheet date and the date on which the financial statements were authorised for issue and have concluded that there are no material adjusting or non-adjusting events requiring disclosure in these financial statements.

22. ULTIMATE CONTROLLING PARTY

The parent of the largest and smallest group for which consolidated financial statements are drawn up is SPD001 Ltd (Registered office - Beech House, Brotherswood Court, Almondsbury, Bristol, England, BS32 4QW).